One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 230,000 shares of Pfizer Inc. (NYSE: PFE | PFE Price Prediction) on Tuesday, as the price of this fund pulled back over 2% in the day’s session. However, it is up a fair amount in the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) parted with 238,235 shares of Pfizer. At Tuesday’s closing price, this would have valued this sale at roughly $11.3 million. This is only a small fraction of the total holdings. The fund is up about 10% over the past 52 weeks.
[nativounit]
Check out all the ARK Invest buys for Tuesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKG | REGN | REGENERON PHARMACEUTICALS | 17,447 |
| ARKG | PFE | PFIZER | 238,235 |
| ARKG | CSTL | CASTLE BIOSCIENCES | 200 |
| ARKG | CLLS | CELLECTIS | 25,000 |
| ARKK | PRLB | PROTO LABS | 23,707 |
| ARKK | U | UNITY SOFTWARE | 121,968 |
| ARKQ | U | UNITY SOFTWARE | 47,465 |
| ARKW | RBLX | ROBLOX | 82,267 |
| ARKW | U | UNITY SOFTWARE | 33,281 |
| ARKX | U | UNITY SOFTWARE | 5,343 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
[recirclink id=989036][wallst_email_signup]